Daniel Ansari
31 – 40 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Proteomic and genomic profiling of pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Diagnosis and management of duodenal perforations : a narrative review
(
- Contribution to journal › Scientific review
-
Mark
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
(
- Contribution to journal › Article
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Early-onset pancreatic cancer : a population-based study using the SEER registry
(
- Contribution to journal › Article
-
Mark
Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype
(
- Contribution to journal › Article
-
Mark
Intraductal Papillary Mucinous Neoplasms of the Pancreas : A Nationwide Registry-Based Study
(
- Contribution to journal › Article